Investors
Information Disclosure
-
NEXT DAY DISCLOSURE RETURN2022.04.07
-
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL OF CATEGORY I NEW DRUG "TQC2938" INJECTION2022.04.07
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 20222022.04.01
-
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 20212022.03.31
-
SHARE PURCHASE PLAN2022.03.31
-
FINAL DIVIDEND FOR 20212022.03.31
-
VOLUNTARY ANNOUNCEMENT CATEGORY I ANTI-TUMOUR INNOVATIVE MEDICINE FHND5071 OBTAINED APPROVAL FOR CLINICAL TRIAL2022.03.29
-
VOLUNTARY ANNOUNCEMENT - “METHACHOLINE CHLORIDE POWDER FOR SOLUTION, FOR INHALATION” OBTAINED DRUG REGISTRATION CERTIFICATE2022.03.28